Abstract
Bayesian analysis is a statistical approach that updates the probability of a hypothesis as new evidence emerges, combining prior knowledge with observed data to produce posterior probabilities. It is particularly useful in adaptive clinical trials and hierarchical modeling, offering flexibility and dynamic decision-making. Machine learning (ML), on the other hand, leverages algorithms to analyze complex patterns in large datasets, providing predictive insights for risk assessment and personalized treatment. Techniques such as deep learning and clustering enhance diagnostic accuracy and treatment optimization. Together, Bayesian methods and ML have the potential to revolutionize cardiothoracic research by integrating prior knowledge with data-driven analytics.